Monday, 11 October 2010

Antibody that acts as a decoy for mysotatin and binds it before it starts muscle growth inhibition. - Duchennepedia - Action Duchenne - Fighting for a cure for muscular dystrophy

Antibody that acts as a decoy for mysotatin and binds it before it starts muscle growth inhibition. - Duchennepedia - Action Duchenne - Fighting for a cure for muscular dystrophy: "CAMBRIDGE, Mass. – May 5, 2010 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the initiation of a Phase 2 clinical trial with ACE-031 in patients with Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease. ACE-031 is an investigational protein therapeutic that builds muscle and increases strength by inhibiting signaling of a cell surface receptor called the activin receptor type IIB (ActRIIB)."

No comments:

Post a comment